1933 INDUSTRIES WKN: A2N61A ISIN: CA65442F1053 Kürzel: 1QF Forum: Aktien Thema: Hauptdiskussion

spitzen volumen...

gab es News?

Ich könnte mir vorstellen, dass 1933 zum Übernahmeziel wird. Bei der Bewertung und dem Kurs zur Zeit. Aber n. m. M.

sehr positiv oder sehe ich das falsch??

https://www.prnewswire.com/news-releases/1933-industries-announces-first-quarter-2019-financials-300769973.html

Marapharm ist auch seit Januar an der OTCQX. :-) Großartige Qualitätskontrolle dieser Börsenplatz. Einfach nicht zuviel reininterpretieren.

Dem Kurs leider egal.

super news

https://www.prnewswire.com/news-releases/1933-industries-graduates-to-the-otcqx-best-market-in-the-us-300761201.html

heftiges volumen!

Fiskalische 2018-Jahres-Highlights: • Umsatz Umsatz von $ 12,649,926 für das Jahr • Gesamt brutto spannen für 2018 von 49 % • die Aktiva sind auf 41,339,616 $ gestiegen. • Produkt-Angebot auf über 120 sku verfügbar in über 500 stores #1933Industries #1933IndustriesBrands #TGIF #TGIFF

Dann sollte es kräftig Richtung Norden gehen :-)

Servus. Auch für euch eine gute Nachricht: https://www.hanf-magazin.com/news/luxemburgs-regierungskoalition-beschliesst-cannabis-legalisierung/

neee

1933 Industries Inc. Announces Fourth Quarter and Year End Financial Results 1933 Industries Inc. is pleased to announce financials for the fourth quarter and the year ending July 31st, 2018. All amounts expressed are in Canadian dollars unless stated otherwise. Fiscal 2018 Highlights Record sales revenues of $12,649,926 for the year Overall gross margins for 2018 of 49% Total assets increased to $41,339,616 Product offering expanded to over 120 SKU’s available in over 500 Stores “We are very pleased with the results of our first full year of operations as a public entity and we have experienced substantial growth through our operating subsidiaries. 1933 has invested significant capital in building out our new cultivation and production facilities in Las Vegas, which will be operational in the new year,” stated Mr. Brayden Sutton, President and CEO of the Company. He added, “The Company is actively expanding its footprint in Nevada, California, Colorado and is currently evaluating opportunities in other legal jurisdictions.” Selected Annual Information The Company recorded annual revenue of $8,214,915 and $4,335,768 generated from AMA and Infused respectively. Net loss for the year ended July 31, 2018 was $5,729,052. The Company’s loss was primarily driven by investment in future growth initiatives. Alternative Medicine Association (“AMA” - 91% ownership) AMA contributed 65% to the Company’s total revenue AMA generated an overall gross margin of 37% ($3,272,703) The positive contributing income before tax from AMA is $1,353,485 Infused Manufacturing (“Infused” - 91% ownership) Infused contributed 34% of the Company’s total revenue Infused generated an overall gross margin of 71% ($3,078,763) Infused broke even in its first full year of operations Consolidated Results 2018 2017 2016 Total revenue $ 12,649,926 $ 1,030,297 $ Gross profit 6,450,709 230,714 Net loss (5,729,052) (2,740,657) (3,674,780) Comprehensive loss (4,791,300) (3,793,029) (3,674,780) Basic and diluted loss per share (0.02) (0.06) (0.10) 2018 2017 2016 Current assets $ 13,398,978 $ 1,971,873 $ 24,693 Total assets 41,339,616 18,897,362 413,693 Current liabilities 2,391,088 2,890,483 707,568 Total liabilities 4,356,119 2,890,483 707,568 2018 Fourth Quarter Highlights

Ist es jetzt plötzlich wieder in Deutschland handelbar?